KARA GOODING: Open Payments
NPI 1538155320 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188,503 in 394 payments from 19 companies in 2025. Trend: 2023 $157,095 · 2024 $162,859 · 2025 $188,503
Speaker / faculty: $112,494Consulting: $40,645Travel & lodging: $27,896Food & beverage: $7,467
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 82 | $49,242 |
| Janssen Biotech, Inc. | 55 | $42,154 |
| UCB, Inc. | 55 | $25,381 |
| Lilly USA, LLC | 31 | $20,025 |
| Incyte Corporation | 36 | $15,368 |
| Arcutis Biotherapeutics, Inc. | 27 | $12,490 |
| Amgen Inc. | 25 | $11,028 |
| PFIZER INC. | 7 | $5,536 |
| Galderma Laboratories, L.P. | 18 | $5,089 |
| LEO Pharma AS | 4 | $731 |
Products named: TREMFYA, ADBRY, Bimzelx, EBGLYSS, ANZUPGO, OPZELURA, Zoryve, CIBINQO.
Industry payments across AZ — which companies pay providers there.
